Normal service resumed? – Swiss-style claims and extensions of patent term

The Australian Patent Office has issued recent decisions (ThromboGenics NV [2015] APO 44 and AbbVie Biotechnology Ltd [2015] APO 45) finding that an extension of patent term will not be allowed in respect of Swiss-style claims.   Background Marketing of pharmaceuticals in Australia requires approval by the Therapeutic Goods Administration and inclusion in the Australian